Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 289

1.

Hierarchical clustering of human papilloma virus genotype patterns in the ASCUS-LSIL triage study.

Wentzensen N, Wilson LE, Wheeler CM, Carreon JD, Gravitt PE, Schiffman M, Castle PE.

Cancer Res. 2010 Nov 1;70(21):8578-86. doi: 10.1158/0008-5472.CAN-10-1188.

2.

Multiple human papillomavirus infections with high viral loads are associated with cervical lesions but do not differentiate grades of cervical abnormalities.

Schmitt M, Depuydt C, Benoy I, Bogers J, Antoine J, Arbyn M, Pawlita M; VALGENT Study Group..

J Clin Microbiol. 2013 May;51(5):1458-64. doi: 10.1128/JCM.00087-13.

3.

Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.

Castle PE, Stoler MH, Wright TC Jr, Sharma A, Wright TL, Behrens CM.

Lancet Oncol. 2011 Sep;12(9):880-90. doi: 10.1016/S1470-2045(11)70188-7.

PMID:
21865084
4.

Human papillomavirus genotypes in cervical intraepithelial neoplasia grade 3.

Castle PE, Schiffman M, Wheeler CM, Wentzensen N, Gravitt PE.

Cancer Epidemiol Biomarkers Prev. 2010 Jul;19(7):1675-81. doi: 10.1158/1055-9965.EPI-10-0251.

5.

Risk of precancer determined by HPV genotype combinations in women with minor cytologic abnormalities.

Gage JC, Schiffman M, Solomon D, Wheeler CM, Gravitt PE, Castle PE, Wentzensen N.

Cancer Epidemiol Biomarkers Prev. 2013 Jun;22(6):1095-101. doi: 10.1158/1055-9965.EPI-12-1455.

6.

Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.

Arbyn M, Roelens J, Simoens C, Buntinx F, Paraskevaidis E, Martin-Hirsch PP, Prendiville WJ.

Cochrane Database Syst Rev. 2013 Mar 28;(3):CD008054. doi: 10.1002/14651858.CD008054.pub2. Review.

PMID:
23543559
7.
8.

Triage of women with ASCUS and LSIL on Pap smear reports: management by repeat Pap smear, HPV DNA testing, or colposcopy?

Ferris DG, Wright TC Jr, Litaker MS, Richart RM, Lorincz AT, Sun XW, Borgatta L, Buck H, Kramer L, Rubin R.

J Fam Pract. 1998 Feb;46(2):125-34.

PMID:
9487318
9.

Effects of age and human papilloma viral load on colposcopy triage: data from the randomized Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS).

Sherman ME, Schiffman M, Cox JT; Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study Group..

J Natl Cancer Inst. 2002 Jan 16;94(2):102-7.

11.

Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.

Manos MM, Kinney WK, Hurley LB, Sherman ME, Shieh-Ngai J, Kurman RJ, Ransley JE, Fetterman BJ, Hartinger JS, McIntosh KM, Pawlick GF, Hiatt RA.

JAMA. 1999 May 5;281(17):1605-10.

PMID:
10235153
12.

Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.

Kulasingam SL, Hughes JP, Kiviat NB, Mao C, Weiss NS, Kuypers JM, Koutsky LA.

JAMA. 2002 Oct 9;288(14):1749-57.

PMID:
12365959
13.

Risk of precancer and follow-up management strategies for women with human papillomavirus-negative atypical squamous cells of undetermined significance.

Safaeian M, Solomon D, Wacholder S, Schiffman M, Castle P.

Obstet Gynecol. 2007 Jun;109(6):1325-31.

PMID:
17540804
14.
15.

HPV testing for triage of HIV-infected women with papanicolaou smears read as atypical squamous cells of uncertain significance.

Massad LS, Schneider MF, Watts DH, Strickler HD, Melnick S, Palefsky J, Anastos K, Levine AM, Minkoff H.

J Womens Health (Larchmt). 2004 Mar;13(2):147-53.

PMID:
15072728
16.

Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance.

ASCUS-LSIL Traige Study (ALTS) Group..

Am J Obstet Gynecol. 2003 Jun;188(6):1383-92.

PMID:
12824967
17.

Human papillomavirus (HPV) genotypes in women with cervical precancer and cancer at Kaiser Permanente Northern California.

Castle PE, Shaber R, LaMere BJ, Kinney W, Fetterma B, Poitras N, Lorey T, Schiffman M, Dunne A, Ostolaza JM, McKinney S, Burk RD.

Cancer Epidemiol Biomarkers Prev. 2011 May;20(5):946-53. doi: 10.1158/1055-9965.EPI-10-1267.

18.

Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer.

Guan P, Howell-Jones R, Li N, Bruni L, de Sanjosé S, Franceschi S, Clifford GM.

Int J Cancer. 2012 Nov 15;131(10):2349-59. doi: 10.1002/ijc.27485.

19.

HPV genotyping for triage of women with abnormal cervical cancer screening results: a multicenter prospective study.

Nakamura Y, Matsumoto K, Satoh T, Nishide K, Nozue A, Shimabukuro K, Endo S, Nagai K, Oki A, Ochi H, Morishita Y, Noguchi M, Yoshikawa H.

Int J Clin Oncol. 2015 Oct;20(5):974-81. doi: 10.1007/s10147-015-0789-4.

PMID:
25652908
20.

Comparison of measurements of human papillomavirus persistence for postcolposcopic surveillance for cervical precancerous lesions.

Gage JC, Schiffman M, Solomon D, Wheeler CM, Castle PE.

Cancer Epidemiol Biomarkers Prev. 2010 Jul;19(7):1668-74. doi: 10.1158/1055-9965.EPI-09-1286.

Items per page

Supplemental Content

Support Center